Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01934621
Other study ID # PRO13070029
Secondary ID R01HD074693
Status Completed
Phase N/A
First received
Last updated
Start date November 2013
Est. completion date September 2020

Study information

Verified date November 2020
Source University of Pittsburgh
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Individuals with cognitive impairments after stroke sustain significant disability in their daily tasks, and account for a significant proportion of stroke-related healthcare costs. The proposed study examines a novel intervention, strategy training, that shows promise for helping individuals with stroke-related cognitive impairments reduce disability in daily tasks, which may lead to reductions in healthcare costs. We predict that strategy training will result in significantly greater independence 6 months after stroke compared to an attention control intervention, and that strategy training may reduce cognitive impairments.


Recruitment information / eligibility

Status Completed
Enrollment 128
Est. completion date September 2020
Est. primary completion date May 2018
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - primary diagnosis of acute stroke - admission to acute inpatient rehabilitation - impairment in higher order cognitive functions (EXIT-14 = 3) Exclusion Criteria: - pre-stroke diagnosis of dementia in the medical record - inability to follow two- step commands 80% of the time - severe aphasia (BDAE = 1) - current major depressive, bipolar, or psychotic disorder - drug or alcohol abuse within 3 months

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
Strategy Training

Attention Control


Locations

Country Name City State
United States University of Pittsburgh Pittsburgh Pennsylvania

Sponsors (2)

Lead Sponsor Collaborator
University of Pittsburgh Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Change in Independence with Daily Activities Moderate effect size of difference between groups in independence (measured with the Functional Independence Measure) Baseline to Month 6
Secondary Change in Executive Functions Moderate effect size of difference between groups in independence (measured with selected indices of the Delis-Kaplan Executive Function System) Baseline to Month 6
See also
  Status Clinical Trial Phase
Terminated NCT03593876 - Strategy Training for People With Aphasia After Stroke N/A
Completed NCT03253601 - iADAPT to Support Strategy Training After Stroke N/A